Our findings imply that increased palmitoleic acid (16:1n-7) proportion, a product related to SCD1(16) activity, not only increases the likelihood of abdominal fat accumulation, but also obesity-related metabolic abnormalities. This evidence concerns the gene SCD and Obesity.